Article

OTC MEVACOR GETS THUMBS DOWN AGAIN-January 2008

Merck & Co Inc's third bid

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image Credit: shidlovski | stock.adobe.com
Related Content
Brain disease dementia problems with loss of memory function for alzheimers as a medical health care icon of neurology and mental illness as a pencil erasing neuron cells from the human anatomy. | Image Credit: Best_Seller | stock.adobe.com
September 17th 2025

Advances in Alzheimer Disease Treatment: A Transformative Time for Pharmacists

Anjeza Fero, PharmD, RPh
Pharmacy Focus Oncology Edition Podcast
September 17th 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
US FDA homepage, biosimilars -- Image credit: IB Photography | stock.adobe.com
September 17th 2025

FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab

Gillian McGovern, Associate Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 17th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Vintage 1951 Vial of PENICILLIN G Produced by CSC Pharmaceuticals division of Commercial Solvents Corporation, New York, USA | Image Credit: Walter Cichetti | stock.adobe.com
September 17th 2025

Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation

Caitlyn Jerkins, PharmD Tracey Bastian, PharmD Rebecca Stern, MD Tyler Baumeister, PharmD, BCIDP
RSV vaccine vial with syringe - Respiratory syncytial virus shot - Image credit: MargJohnsonVA | stock.adobe.com
September 17th 2025

Study Shows AOV System Reduces Errors in RSV Vaccine Preparation

Kennedy Ferruggia, Assistant Editor
© 2025 MJH Life Sciences

All rights reserved.